US company to invest in project trying to bring back Tasmanian tiger

American biotech company Colossal Biosciences is set to invest $10 million in a University of Melbourne project aiming to bring the Tasmanian tiger back from extinction.

The funding, in conjunction with $5 million in private donations, will allow a team of 50 scientists to work on the project.

The Tasmanian tiger, otherwise known as the Thylacine, has been extinct since 1936.

Leave a Reply

Your email address will not be published. Required fields are marked *